Related Experiment Video
Updated: May 12, 2025
07:26
Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
Published on: July 14, 2021
5.0K
Significant Improvement in Atherosclerotic Risk Factors From Intensive Cardiac Rehabilitation (Dean Ornish Program)
Samuel A Miller1, Ghaith Al Tibi, Joseph Khoury
1Author Affiliations: RUSH Medical College, Chicago, Illinois (Mr Miller); Albert Einstein College of Medicine, Bronx, New York (Mr Al Tibi and Mr Khoury); Georgia Institute of Technology, Atlanta, Georgia (Mr Ayesh).; and Lake Country Medical Group, Eatonton, Georgia (Ms Barker, Ms Butera, and Dr Chronos).
Summary
No abstract available in PubMed .
More Related Videos
Related Concept Videos
01:20Exercise and Cardiovascular Response
650
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
650
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
316
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
316